CONMED Corporation

NYSE:CNMD

Medical - Devices

Healthcare
$48.01 +0.75%

+$0.24 today

Market cap
$1.43B
Beta
0.92
P/E (TTM)
18.0
EPS (TTM)
$1.79
Dividend yield
1.24%
52W Low $31.84High $56.64

Volume 0.36M

Average 0.45M

CNMD Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

CONMED CorporationNYSE: CNMD

Deferred Revenue · Q1 FY2026 · quarter ended Mar 2026

Deferred revenue remains negative

Q1 FY2026 deferred revenue was $0, compared with $0 a year earlier.

Context

  • Deferred revenue amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Deferred revenue increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Deferred Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Deferred Revenue history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Deferred Revenue vs competitors

How CNMD compares with its peers on the latest reported figures

  • CNMD's Mar 2026 deferred revenue of $0 is the 8th highest of the 11 companies compared; the peer median is $3.59M.
  • Deferred revenue amounts to 0.0% of total assets for CNMD, versus a peer median of 0.4%.
CNMD Competitors Peer median
Deferred Revenue for CNMD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
AHCOAdaptHealth Corp.Apr 2026$59.73M +28.6%+23.7%1.4%
AZTAAzenta, Inc.Sep 2026$40.08M -31.0%+5.0%2.3%
INMDInMode Ltd.Mar 2026$16.37M +3.2%—2.2%
UFPTUFP Technologies, Inc.Jun 2026$4.8M +4.2%-3.2%0.7%
NEOGNeogen CorporationAug 2026$3.6M -38.2%-8.0%0.1%
SSIISS Innovations International, Inc.Mar 2026$3.58M +91.5%+1125.2%4.0%
NTLAIntellia Therapeutics, Inc.Mar 2026$630K -97.0%-45.0%0.1%
CNMDCONMED CorporationMar 2026$0 ——0.0%
ESTAEstablishment Labs Holdings Inc.Sep 2026$0 -100.0%-10.6%0.0%
KMTSKestra Medical Technologies, Ltd.Jan 2026$0 -100.0%—0.0%
NVCRNovoCure LimitedMar 2026$0 —-4.0%0.0%
Peer median (excluding CNMD) $3.59M-31.0%-3.6%0.4%

Competitors are the stored peer set for CNMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents20.85M28.94M24.3M24.46M40.82M
Short-term Investments00000
Net Receivables183.88M191.35M242.28M237.73M247.83M
Inventory231.64M332.32M318.32M346.72M355.54M
Other Current Assets4.9M28.62M30.75M31.1M28.67M
Total Current Assets460.12M581.23M615.65M640.01M672.86M
Property, Plant & Equipment (Net)108.86M115.61M120.72M115.79M113.33M
Goodwill617.53M815.43M806.84M805.36M807.01M
Intangible Assets471.05M681.8M649.48M617.66M582.05M
Long-term Investments00000
Tax Assets9.66M9.65M11.21M11.07M13.31M
Other Non-current Assets98.8M93.88M96.11M116.36M137.19M
Total Non-current Assets1.31B1.72B1.68B1.67B1.65B
Total Assets1.77B2.3B2.3B2.31B2.33B
Account Payables58.2M73.39M88.22M102.25M93.65M
Short-term Debt12.25M69.75M8.22M715K712K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities126.2M153.41M138.07M175.17M220.68M
Total Current Liabilities196.65M296.55M310.73M278.13M315.04M
Long-term Debt672.41M985.08M971.48M905.07M834.23M
Deferred Tax Liabilities68.54M66.73M60.9M74.08M79.53M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities42.99M203.69M111.13M86.29M63.85M
Total Non-current Liabilities783.94M1.26B1.16B1.07B977.61M
Total Liabilities980.58M1.55B1.47B1.34B1.29B
Common Stock313K313K313K313K313K
Retained Earnings496.61M412.63M452.53M560.28M588.77M
Accumulated OCI(54.2M)(57.86M)(50.17M)(58.86M)(46.3M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity785.44M745.55M834.22M962.68M1.03B
Total Debt684.66M1.05B991.25M905.78M834.94M
Net Debt663.81M1.03B966.96M881.32M794.13M

CONMED Corporation

NYSE:CNMD

Intrinsic Alpha fair value

Locked

Current Price

$48.01

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.